Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process
The rapid and global propagation of the novel human coronavirus that causes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has produced an immediate urgency to discover promising targets for the treatment of this virus. In this paper, we studied the spike protein S2 domain of SARS-CoV-...
Main Authors: | Davide Gentile, Alessandro Coco, Vincenzo Patamia, Chiara Zagni, Giuseppe Floresta, Antonio Rescifina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/17/10067 |
Similar Items
-
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design
by: Giuseppe Floresta, et al.
Published: (2022-03-01) -
Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of <i>Curcuma longa</i> as Potential Lead Inhibitors of ERBB and VEGFR-2 for the Treatment of Colorectal Cancer
by: Syeda Abida Ejaz, et al.
Published: (2023-05-01) -
Discovery of GABA Aminotransferase Inhibitors via Molecular Docking, Molecular Dynamic Simulation, and Biological Evaluation
by: Muhammad Yasir, et al.
Published: (2023-11-01) -
Identification of BACE-1 Inhibitors against Alzheimer’s Disease through E-Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation Studies: An Insilco Approach
by: Kumarappan Chidambaram
Published: (2023-04-01) -
Identification of CDK7 Inhibitors from Natural Sources Using Pharmacoinformatics and Molecular Dynamics Simulations
by: Vikas Kumar, et al.
Published: (2021-09-01)